Mesoblast has done a lot research and trials relating to blood cancers, through the use of extracting adult stem cells from bone marrow.
- Forums
- ASX - By Stock
- MSB
- Ann: Partnership For Allogeneic Cell-based Cancer Immunotherapies
Ann: Partnership For Allogeneic Cell-based Cancer Immunotherapies, page-30
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.09 |
Change
-0.035(3.11%) |
Mkt cap ! $1.255B |
Open | High | Low | Value | Volume |
$1.12 | $1.13 | $1.09 | $3.049M | 2.770M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
23 | 72290 | $1.09 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.10 | 66666 | 21 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
20 | 74578 | 1.090 |
22 | 159215 | 1.085 |
24 | 302895 | 1.080 |
16 | 253694 | 1.075 |
13 | 575302 | 1.070 |
Price($) | Vol. | No. |
---|---|---|
1.095 | 64594 | 17 |
1.100 | 213297 | 20 |
1.105 | 197895 | 15 |
1.110 | 269510 | 11 |
1.115 | 79276 | 5 |
Last trade - 13.45pm 18/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |